Delivery Order SPE2DB24D1034-SPE2DB24FVYK5
Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The $1,642.50 firm fixed-price contract has an ultimate completion date of August 11, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $2,375.20 firm fixed price delivery order has a completion date of June 3, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, valued at $3,514.49, is for Lantus Solostar 100 unit/mL 3mL insulin pens. The contract has a firm fixed price pricing type and a period of performance through June 14, 2022. This delivery order is not designated as a set-aside contract....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,151.88 firm fixed price Delivery Order was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 21, 2024, with a completion date of June 24, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The $5,741.15 firm fixed-price contract has a completion date of February 21, 2023. No set-aside was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
- This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.45 firm-fixed-price contract is for the supply of Lantus Solostar insulin pens (100 unit/mL, 3mL) and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Lantus Solostar insulin pens. The contract has a ceiling value of $1,768.16 and a completion date of May 22, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, valued at $2,375.20, is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The order has a firm fixed price and a completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical to provide a wide range of medical commodities,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,956.18 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB24FVYK5Delivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The $1,529.21 firm-fixed-price contract has a completion date of March 8, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Generated 5/14/25, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 3/7/24 |